A trial of transplanting Hepatitis C-viremic kidneys into

Recruiting

99 years or below

All

Phase 2

50 participants needed

1 Location

Brief description of study

The THINKER-NEXT research study is being done to determine whether it is safe to give a kidney transplant from a donor with hepatitis C to a patient without hepatitis C. The recipient will then be given a drug called Epclusa for 12 weeks to treat hepatitis C. Patients who are on the kidney transplant waitlist and do not have hepatitis C will be asked to participate.

Eligibility of study

You may be eligible for this study if you meet the following criteria:

Conditions: Hepatitis C,renal
Age: 99 years or below
Gender: All

Updated on 04 Aug 2024. Study ID: 842809

Find a site

Your Information has been sent successfully.

We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.

Would you like to be notified about other trials? Sign up for Patient Notification Services.

Send a message

Enter your contact details to connect with study team

Primary Contact

First name*

Last name*

Email*

Phone number*

Preferred way of contact

Race

Ethnicity

Are you Healthy Volunteer

Are you comfortable with the informed consent process?

Yes

Other language

By sending a message, I agree that my data will be sent to a representative for the selected site and processed in accordance with this website's Privacy Policy (see link in footer).

A trial of transplanting Hepatitis C-viremic kidneys into Hepatitis C-Negative kidney recipients

Brief description of study

Eligibility of study

Find a site

Interested in the study